The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 09, 2018
Filed:
Apr. 30, 2016
Applicant:
Fairhaven Health, Llc, Bellingham, WA (US);
Inventor:
Suzanne Munson, Bellingham, WA (US);
Assignee:
Fairhaven Health, LLC, Bellingham, WA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/43 (2006.01); A61K 31/205 (2006.01); A61K 31/122 (2006.01); A61K 31/714 (2006.01); A61K 31/195 (2006.01); A61K 36/87 (2006.01); A61K 31/198 (2006.01); A61K 31/01 (2006.01); A61K 31/375 (2006.01); A61K 31/593 (2006.01); A61K 31/355 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/455 (2006.01); A61K 31/4188 (2006.01); A61K 33/18 (2006.01); A61K 33/30 (2006.01); A61K 33/00 (2006.01); A61K 33/34 (2006.01); A61K 33/32 (2006.01); A61K 33/24 (2006.01); A23L 1/305 (2006.01); A23L 1/302 (2006.01); A23L 1/30 (2006.01); A23L 1/304 (2006.01); A23L 1/29 (2006.01); A61K 45/06 (2006.01); A61K 31/07 (2006.01); A61K 31/197 (2006.01); A61K 31/4415 (2006.01); A61K 33/04 (2006.01); A23L 33/10 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A23L 33/175 (2016.01);
U.S. Cl.
CPC ...
A61K 36/87 (2013.01); A23L 1/296 (2013.01); A23L 1/30 (2013.01); A23L 1/302 (2013.01); A23L 1/3002 (2013.01); A23L 1/304 (2013.01); A23L 1/3051 (2013.01); A23L 33/10 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A61K 31/01 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/525 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/18 (2013.01); A61K 33/24 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract
The present invention relates to a fertility-enhancing composition for human male fertility therapy and a method for using the same to improve or enhance human male fertility. The nutritional supplement composition of the invention includes an effective amount of L-carnitine, coenzyme Q10, vitamin B, N-acetyl L-cysteine, and grape seed extract.